Larger volumes drug delivery require a new product concept, a large-volume wearable injector
Large volume wearable injectors are devices that are used to deliver high volume of drugs usually in the range of 2 – 50 ml of drug within 2 – 15 minutes. There are many chronic conditions, which require prolonged and continuous drugs delivery and introduction of wearable injectors are one of the achievement in the field of novel drugs delivery systems. Many global pharmaceutical companies are developing biologic therapeutics, which are basically rooted onto monoclonal antibodies for the treatment of autoimmune disorders and immuno-oncology drugs. With the busy lifestyle there is a low possibility of regular intake of drugs through injections, typically weekly, biweekly or monthly by people suffering from various chronic conditions that require constant medication. Wearable injectors offer the perfect solution in terms of portability and precise dosage administration.
Drugs with longer half-lives, the pharma companies need think the pros and cons between injections and auto-injector and less common injections from a wearable injector
According to Vice-President, Corporate Development, Enable Injections, the increased cost to bring a single pharmaceutical drug into market, which is estimated to be around US$ 2.6 billion in 2015, is a huge expenditure for a new developing pharma company and have a greater burden to make the most of revenue and stay ahead of many pharma and medical device competitors. Pioneering products are high risk/high reward, with various companies focusing on developing first-in-class treatments, with only the most effective surviving in the market. The collaboration between various companies makes provides for highly lucrative opportunities for both large volume wearable injectors market and wearable medical devices market.
Adhesive patches injectors the leading product in the large volume wearable injector market
The global large volume wearable injectors market is segmented on the basis of injector, by usage, by injector mechanism, by therapeutic area, by end user, and geography. On the basis of type of injector, the market is divided into, on-body, off body and hand held. On basis of usage, the market is divided into disposable and reusable. On basis of injector mechanism, the market is divided into spring-based, pressurized gas, motor driven, rotary pump and expandable battery. On basis of therapeutic area, the large volume wearable injectors market is divided into oncology, diabetes, cardiovascular, auto-immune disorders, infectious disease and others. On basis of end user, the market is divided into hospitals, home care settings, clinics, and ambulatory surgical centers, and others.
Collaboration of Pharma and Medical Devices companies to Put Large Volume Wearable Injectors Market on high growth trajectory
Regional segmentation of the large volume wearable injector market by Coherent Market Insights comprises North America, Europe, Asia Pacific, Latin America, Middle East, and Africa. North America to hold the major chunk of large volume wearable injectors as many medical device and pharma companies combined together has their research and development centers in U.S., which makes early accessibility of advanced technologies and higher penetration of health care services. For instance, Amgen launched a therapeutic product used to deliver the 70mg of drug every week and then the modification of product transformed weekly dose regime to monthly. This can be used with either a Prefilled Syringe or Auto Injector. With advancements in technology, the company developed a wearable injector, which was approved by US FDA and this device is available in the U.S. since 2016. The other factors fueling growth of the large volume wearable injector market are better marketing, efficacy in long term dosage, and predominantly the rising number of patients with chronic long-term disorders.
Manufacturer’s Landscape Evolution - Becton Dickinson and West Pharma and heading towards the heading towards the pole position in Large Volume Wearable Injectors Market
Key players operating the large volume wearable injectors market include SteadyMed Therapeutics, Inc., Enable Injections, UNILIFE CORPORATION, Insulet Corporation, Sensile Medical AG, Becton, Dickinson and Company, West Pharmaceutical Services, Inc., Bühler Motor GmbH, Ypsomed, Amgen Inc., among others. Major pharma and medical companies in the market are constantly working towards introducing innovative products and lowering production costs as many large volume biologics are still under clinical trials. For instance in June 2016, Ypsomed self-care solution collaborated with Novo Nordisk to develop and provide new dimensions in insulin pump therapy.
Coherent Market Insights followsa comprehensive research methodology focused on providing the most precise market analysis. The company leverages a data triangulation model which helps company to gauge the market dynamics and provide accurate estimates. Key components of the research methodologies followed for all our market reports include:
In addition to this, Coherent Market Insights has access to a wide range of the regional and global reputed paid data bases, which helps the company to figure out the regional and global market trends and dynamics. The company analyses the industry from the 360 Degree Perspective i.e. from the Supply Side and Demand Side which enables us to provide granular details of the entire ecosystem for each study. Finally, a Top-Down approach and Bottom-Up approach is followed to arrive at ultimate research findings.
Coherent Market Insights desk research is based on a principle set of research techniques:
Coherent Market Insights has a large amount of in-house repository of industry database. This is leveraged as a burner for initiating a new research study. Key secondary sources include:
Preliminary Data Mining
The raw data is obtained through the secondary findings, in house repositories, and trade surveys. It is then filtered to ensure that the relevant information including industry dynamics, trends, and outlook is retained for further research process.
Holistic approach is used to ensure that the granular and uncommon parameters are taken into consideration to ensure accurate results. The information from the paid databases are further combined to the raw data in order to standardize it.
Coherent Statistical model
We arrive at our final research findings through simulation models. Coherent Data Analytics Model is a statistical tool that helps company to forecast market estimates. Few of the parameters considered as a part of the statistical model include:
Once the findings are derived from the statistical model, large volume of data is process to confirm accurate research results. Data analytics and processing tools are adopted to process large chunk of collected informative data. In case, a client customizes the study during the process, the research finding till then are benchmarked, and the process for new research requirement is initiated again.
This is the most crucial stage of the research process. Primary Interviews are conducted to validate the data and analysis. This helps in achieving the following purposes:
The primary research is conducted with the ecosystem players including, but not limited to:
Finding it difficult to find the research that would cater to your business demands? Give us a chance to help you. One of our Research Consultants will connect to provide a customized solution.[email protected]
Talk to our research consultant to design an exclusive report as per your research needs.
We aim to fulfil client's research demands with tailored research solutions.
We aim to provide research studies in quickest turnaround time and in a much cost effective manner.
We cover each industry from supply and demand side with an aim to provide a most holistic research study.
We strive to provide most accurate and reliable research findings in our research reports.